Acceptance of human papillomavirus vaccine by gynecologists in an urban setting

Journal of Lower Genital Tract Disease

Volumn 12, Issue 2, 2008, Pages 118-121

  Jaspan, David M ^a   Dunton, Charles J ^b   Cook, Traci L ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

^b LANKENAU HOSPITAL   (United States)

Author keywords

HPV vaccine; Physician acceptance; Vaccination rate

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HEALTH PRACTITIONER; HUMAN; MALE; PATIENT ATTITUDE; PATIENT SAFETY; QUESTIONNAIRE; VACCINATION; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; ATTITUDE OF HEALTH PERSONNEL; CHILD; FEMALE; GYNECOLOGY; HEALTH CARE SURVEYS; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; UNITED STATES; URBAN HEALTH SERVICES; VACCINATION;

EID: 41449101561     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/LGT.0b013e31815d9639     Document Type: Article

References (15)

1. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007;56:1-24.
2. Tempte J. HPV vaccine: a cornerstone of female health. Am Fam Physician 2007;75:128.
3. Society of Gynecologic Oncologists. Statement on a cervix cancer vaccine. Gynecol Oncol 2006;101:377-554.
4. Saslow D, Castle PE, Cox JT, Davey DD, Einstein MH, Ferris DG, et al. American Cancer Society Guidelines for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 2007;57:7-28.
5. Committee on Adolescent Health Care. ACOG Working Group on Immunization. ACOG Committee Opinion No. 344. Human papillomavirus vaccination. Obstet Gynecol 2006;108:699-705.
6. Raley JC, Followwill KA, Zimet GD, Ault KA. Gynecologists' attitudes regarding human papillomavirus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists. Infect Dis Obstet Gynecol 2004;12:127-33.
7. Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, et al. Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007;356:1928-43.
8. Anonymous. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007;356:1915-27.
9. Newall AT, Beutels P, Wood JG, Edmunds WJ, MacIntyre CR. Cost-effectiveness analyses of human papillomavirus vaccination. Lancet Infect Dis 2007;7:289-96.
10. Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Med 2007;40:108-15.
11. Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics 2006;117:1486-93.
12. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 2007;45:107-14.
13. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515-25.
14. Jobe AH. Fetal lung development, Tests for Maturation, Induction of Maturation and Treatment. Chapter 27. In: Creasy RK, Resnik R, eds. Maternal Fetal Medicine, 4th ed. Philadelphia: WB Saunders Company; 1984:415.
15. Anonymous. American Academy of Pediatrics. Committee on Infectious Diseases. Varicella vaccine update. Pediatrics 2000;105:136-41.